FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies

被引：54

作者：

Goodridge, Jode P. ^{[1
]}

Mahmood, Sajid ^{[1
]}

Zhu, Huang ^{[2
]}

Gaidarova, Svetlana ^{[1
]}

Blum, Robert ^{[3
]}

Bjordahl, Ryan ^{[1
]}

Cichocki, Frank ^{[4
]}

Chu, Hui-yi ^{[1
]}

Bonello, Greg ^{[1
]}

Lee, Tom ^{[1
]}

Groff, Brian ^{[1
]}

Meza, Miguel ^{[1
]}

Walcheck, Bruce ^{[5
]}

Malmberg, Karl-Johan ^{[6
]}

Miller, Jeffrey S. ^{[7
]}

Kaufman, Dan S. ^{[3
]}

Valamehr, Bahram ^{[1
]}

机构：

[1] Fate Therapeut Inc, San Diego, CA USA

[2] Univ Calif San Diego, San Diego, CA 92103 USA

[3] Univ Calif San Diego, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA

[4] Univ Minnesota, Dept Med, Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA

[5] Univ Minnesota, Minneapolis, MN USA

[6] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Canc Immunol, Inst Canc Res, Stockholm, Sweden

[7] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA

来源：

关键词：

D O I：

10.1182/blood-2019-129319

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

301

引用

页数：5